OPTI-OX
LIVE

Serial Number

79293252

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

Jul 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OPTI-OX Trademark

Serial Number: 79293252 • Registration: 6391962

OPTI-OX is a trademark filed by Bit Bio Limited on July 9, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Trademark Details

Filing Date

July 9, 2020

Registration Date

June 22, 2021

Published for Opposition

April 6, 2021

Goods & Services

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells for medical or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use in drug screening; cell preparations for genetic testing and screening for clinical and medical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies and reagents for medical and diagnostic or clinical use; tissue culture media growth factors in the nature of cell growth, cell growth media and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells all for medical and clinical use; cell separation reagents for medical and clinical use; dietary supplements; protein supplements; nutrition supplements

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Biotechnology research; scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely biological research; stem cell biology services, namely, biological research; scientific services for research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing, screening; research and development in relation to drug screening; cell separation technology services, namely, research of technology in the field of cell separation; cell separation research services; consultancy relating to biotechnology; scientific and research consultancy relating to drug screening for forensic research purposes; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and manufacturing; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; development and testing of computing methods, software algorithms and software for medical, clinical, research and biomanufacturing purposes

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant dna technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements, nutrition supplements, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and control laboratory biomanufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; laboratory apparatus for magnetic cell separation, namely, apparatus for the separation of cell populations for medical or clinical use; all the aforesaid goods excluding use for non-medical oxygen measurement

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 8, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 13, 2021 FICS
FINAL DISPOSITION PROCESSED
Oct 13, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 22, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 5, 2021 GPNX
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 18, 2021 CORN
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
CORRECTION TRANSACTION RECEIVED FROM IB
Feb 28, 2021 CRCV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2021 TROA
REFUSAL PROCESSED BY IB
Nov 9, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 16, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 24, 2020 RFCR
NON-FINAL ACTION WRITTEN
Sep 23, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 15, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 10, 2020 REPR